Institutional portfolios / 13F
AH Equity Partners Bio II, L.L.C.
A closer look at the portfolio, one quarter at a time.
Sign in to follow Export portfolio ↓ Export quarterly changes ↓- Reported portfolio value
- $143,512,000 As of September 30, 2022
- Positions
- 4 Across disclosed securities
- Top 5 weight
- 100.0% Share of reported value
View SEC filing · Published 2022-11-14 14:28 UTC
Inside the portfolio
Reported holdings
Quarterly comparison unavailable: complete reports and corporate-action evidence are required. Reported holdings remain available below.
| Security | Shares / principal | Reported value | Weight | Adjusted quarterly change |
|---|---|---|---|---|
EQRx, Inc.Common Stock · EQRX
Holding detailsReported CUSIP: 26886C107 Reported row 1 · 0001104659-22-117986 Quarterly change unavailable. Security identity or split coverage is incomplete. |
17,438,465 SH | $86,320,000 | 60.15% |
—Comparison unavailable |
Nautilus Biotechnology, Inc.Common Stock · NAUT
Holding detailsReported CUSIP: 63909J108 Reported row 4 · 0001104659-22-117986 Quarterly change unavailable. Security identity or split coverage is incomplete. |
16,298,006 SH | $34,552,000 | 24.08% |
—Comparison unavailable |
Erasca, Inc.Common Stock · ERAS
Holding detailsReported CUSIP: 29479A108 Reported row 2 · 0001104659-22-117986 Quarterly change unavailable. Security identity or split coverage is incomplete. |
2,500,000 SH | $19,500,000 | 13.59% |
—Comparison unavailable |
InVitae CorporationCommon Stock · NVTA
Holding detailsReported CUSIP: 46185L103 Reported row 3 · 0001104659-22-117986 Quarterly change unavailable. Security identity or split coverage is incomplete. |
1,276,541 SH | $3,140,000 | 2.19% |
—Comparison unavailable |